Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

The application of Mycobacterium tuberculosis antigenic protein rv0585c and its T-cell epitope peptide

A technology of Mycobacterium tuberculosis and antigenic protein, which is applied in the fields of molecular biology and immunology, can solve the problems of poor sensitivity, poor specificity of tuberculosis, high price, etc., and achieves the effect of facilitating quality control, reducing false positives, and improving sensitivity

Active Publication Date: 2019-11-22
ICDC CHINA CDC
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the high requirements for the bacterial content in the sample, the sensitivity of this method is not high, resulting in a large number of smear-negative patients being undetected and turning positive, and smear-negative patients are contagious, which cannot be ignored. This method has no species specificity and poor sensitivity , affected by sputum specimen and disease condition
Sputum culture is the gold standard for the diagnosis of tuberculosis, but the culture time is too long. Now there are rapid culture systems such as the BACTECMGIT960 system that can isolate and culture Mycobacterium tuberculosis within 2 weeks. Inhibitors are expensive and cannot be widely used in developing countries, and rapid cultures have significantly higher contamination rates compared to modified L-J cultures, leading to false positive results
The commonly used detection method for population screening is the skin tuberculin test, which uses pure protein derivatives of Mycobacterium tuberculosis (PPD), because PPD contains many mycobacterial species (pathogenic mycobacteria, environmental mycobacteria bacillus and BCG), so the specificity of PPD diagnosis of tuberculosis is poor, and it cannot effectively distinguish between Mycobacterium tuberculosis infection and BCG vaccination. Tuberculosis imaging examinations include routine X-ray examination, CT examination, MRI examination, Ultrasound examinations are expensive, cause certain harm to the body, have low specificity, and are not suitable for routine examination and diagnosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • The application of Mycobacterium tuberculosis antigenic protein rv0585c and its T-cell epitope peptide
  • The application of Mycobacterium tuberculosis antigenic protein rv0585c and its T-cell epitope peptide
  • The application of Mycobacterium tuberculosis antigenic protein rv0585c and its T-cell epitope peptide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Example 1 Cloning of Mycobacterium tuberculosis antigen gene Rv0585c and protein expression and purification

[0045] Rv0585c (GI: 15607725) is a conserved membrane protein encoded by the Mycobacterium tuberculosis H37Rv genome, containing 795 amino acids, and its amino acid sequence is shown in SEQ ID NO:4. According to its coding gene sequence (SEQ ID NO: 5), primers were designed, and the antigenic protein Rv0585c was expressed and purified using a prokaryotic expression system (such as Escherichia coli).

Embodiment 2

[0046] Example 2 Synthesis of Mycobacterium tuberculosis antigenic protein Rv0585c T cell epitope peptide

[0047] Based on the T cell IFN-γ release technology, the T cell epitope on the Rv0585c coding gene was predicted by using the bioinformatics software TE predict and IEDB, and the epitope peptide was synthesized by the solid-state synthesis method, and then the tuberculosis patients, Specific T lymphocytes in patients with other lung diseases and healthy people were detected, so as to evaluate the sensitivity and specificity of the antigen for tuberculosis detection.

[0048] The Mycobacterium tuberculosis antigenic protein Rv0585c T cell epitope peptide provided in this example is selected from P24, P26, and P31, and its amino acid sequences are respectively shown in SEQ ID NO: 1-3.

Embodiment 3

[0049] The preparation of embodiment 3 tuberculosis T-SPOT detection kit

[0050] The basic composition of the test kit is as follows:

[0051] ① The protein antigen Rv0585c prepared in Example 1 and / or the epitope peptide antigen synthesized in Example 2: the epitope peptide is selected from at least one of P24, P26, and P31.

[0052] ② Primary antibody: mouse IgG monoclonal antibody against human or animal IFN-γ.

[0053] Enzyme-labeled reagent: another mouse IgG monoclonal antibody labeled with horseradish peroxidase against different epitopes of human or animal IFN-γ.

[0054] ③Standard product:

[0055] Culture plate: 96-well microwell reaction plate containing PVDF membrane or nitrocellulose membrane, positive control wells contain tuberculosis non-specific stimulating antigen (such as PHA, etc.), negative control wells contain PBS or base solution.

[0056] ④ Other reagents and consumables required for T-SPOT detection.

[0057] The primary antibody was immobilized ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention relates to mycobacterium tuberculosis antigen protein Rv0585c and application of a T cell epitope peptide thereof in preparing tuberculosis detection reagents, vaccines and medicines. The epitope peptide is selected from P24, P26 and P31 which have amino acid sequences shown as SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:3 respectively. A mycobacterium tuberculosis protein antigen Rv0585c and the T cell epitope peptide thereof serve as irritants and are used for specific T cell and B cell immunoreaction caused by mycobacterium tuberculosis infection; compared with an existing adopted complete antigen, the false positive result caused by antigen impurity can be reduced. The detection reagents prepared from the protein antigen Rv0585c and the epitope peptide of the protein antigen Rv0585c can be widely used for auxiliary diagnosis, epidemiological monitoring and other related fields of tuberculosis. Tuberculosis vaccines and antituberculosis medicines prepared from the protein antigen Rv0585c and the epitope peptide of the protein antigen Rv0585c can be used for preventing and treating tuberculosis.

Description

technical field [0001] The invention relates to the fields of molecular biology and immunology, in particular to the application of mycobacterium tuberculosis antigen protein Rv0585c and its T cell epitope peptide in the preparation of tuberculosis detection reagents, vaccines and medicines. Background technique [0002] Tuberculosis is a chronic infectious disease caused by Mycobacterium tuberculosis. Survey results show that one-third of the world's population is latently infected, and 5% to 10% may develop active tuberculosis in future life. Since the World Health Organization declared tuberculosis a global crisis in 1993, the morbidity and mortality of tuberculosis have remained high. According to the WHO report, there are about 8 million new tuberculosis patients every year, and about 2 to 3 million people die of tuberculosis every year. my country ranks second among the 22 countries with a high burden of tuberculosis. The results of the fifth national epidemiological s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/35A61K39/04A61K39/40A61P31/06G01N33/569G01N33/68G01N33/577C12Q1/689C12Q1/04C12R1/32
CPCA61K39/04A61K2039/505A61K2039/53A61K2039/55561C07K14/35C07K16/12C07K2317/24C12Q1/689G01N33/5695G01N33/577G01N33/68
Inventor 万康林李马超王雪枝刘海灿
Owner ICDC CHINA CDC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products